Table 2.
Significant differences in serum and urine biomarkers between healthy horses (non-acute kidney injury (AKI) group), horses at risk of kidney injury (AKI-risk group; divided into colic sufferers, recipients of nonsteroidal anti-inflammatory drugs (NSAIDs) and recipients of gentamicin) and horses diagnosed with acute kidney injury (AKI group)
| Parameter | Non-AKI vs | AKI-risk colic vs | AKI-risk NSAIDs vs | AKI-risk gentamicin vs | ||||
|---|---|---|---|---|---|---|---|---|
| AKI | Non-AKI | AKI | Non-AKI | AKI | Non-AKI | AKI | ||
| NGAL (ng/mL) | Serum | 0.0030 | - | - | - | 0.0030 | - | 0.0200 |
| Urine | 0.0050 | 0.0050 | - | - | - | - | - | |
| Cystatin C (mg/L) | Serum | 0.0400 | - | - | - | 0.0400 | - | 0.0200 |
| Urine | 0.0001 | 0.0400 | - | - | 0.0400 | - | 0.0300 | |
NGAL – neutrophil gelatinase-associated lipocalin